Tom Rice - Mar 15, 2024 Form 4 Insider Report for PACIFIC PREMIER BANCORP INC (PPBI)

Role
SEVP/ Chief Innovation Officer
Signature
/s/ Tom Rice
Stock symbol
PPBI
Transactions as of
Mar 15, 2024
Transactions value $
-$165,596
Form type
4
Date filed
3/19/2024, 07:18 PM
Previous filing
Dec 1, 2023
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PPBI PPBI Common Stock Award $0 +15.5K +47.07% $0.00 48.4K Mar 15, 2024 Direct F1
transaction PPBI PPBI Common Stock Options Exercise +3.72K +7.69% 52.1K Mar 15, 2024 Direct F2
transaction PPBI PPBI Common Stock Options Exercise +483 +0.93% 52.6K Mar 15, 2024 Direct F3
transaction PPBI PPBI Common Stock Tax liability -$166K -7.32K -13.93% $22.61 45.2K Mar 15, 2024 Direct F4, F5
transaction PPBI PPBI Common Stock Gift $0 -6.64K -14.67% $0.00 38.6K Mar 19, 2024 Direct F5, F6
transaction PPBI PPBI Common Stock Gift $0 +6.64K +10.29% $0.00 71.1K Mar 19, 2024 By The Rice Family Trust F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PPBI PPBI Restricted Stock Unit Award $0 +15.5K $0.00 15.5K Mar 15, 2024 PPBI Common Stock 15.5K Direct F7, F8
transaction PPBI PPBI Restricted Stock Unit Options Exercise $0 -5.75K -100% $0.00* 0 Mar 15, 2024 PPBI Common Stock 5.75K Direct F2, F7, F8
transaction PPBI Dividend Equivalent Rights Options Exercise -483 -100% 0 Mar 15, 2024 PPBI Common Stock 483 Direct F3, F8
holding PPBI PPBI Restricted Stock Unit 9.48K Mar 15, 2024 PPBI Common Stock 9.48K Direct F7, F8
holding PPBI PPBI Restricted Stock Unit 14.1K Mar 15, 2024 PPBI Common Stock 14.1K Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock with an evenly distributed 3-year vesting schedule.
F2 On March 15, 2021, Reporting Person was granted Restricted Stock Units which convert into common stock on a one-for-one basis, the vesting of which was conditioned upon the achievement of certain performance goals. On March 15, 2024, actual performance against goals for the applicable performance period was determined and the Reporting Person was awarded 3,720 shares of common stock.
F3 Each dividend equivalent right is the economic equivalent of one share of common stock. Dividend equivalent rights accrue on the reporting person's Restricted Stock Units and become vested proportionately with the Restricted Stock Units.
F4 Represents shares withheld to cover the tax liability incident to the vesting of Restricted Stock Units, Restricted Stock Awards and dividend equivalent rights.
F5 Includes 36,007 shares of restricted stock subject to a vesting schedule set forth in the restricted stock grant and subject to forfeiture upon the occurrence of certain events specified in the restricted stock grant.
F6 On March 19, 2024, the reporting person transferred 6,637 directly owned shares of PPBI common stock to the Rice Family Trust, dated March 28, 2018 (the "Trust"), Tom Rice, Co-Trustee. The reporting person shares voting and dispositive control over shares held by the Trust.
F7 Each Restricted Stock Unit represents the right to receive one share of common stock. The amount reported reflects the targeted number of Restricted Stock Units that may vest, if at all, following the third anniversary of the date of grant upon confirmation of achievement of certain predetermined performance goals over a 3-year performance period. Depending on the actual performance achieved, the reporting person may receive between 0% and 200% of the targeted amount. 50% vesting will be based on the Company's 3-year average relative total shareholder return percentile range compared to the Keefe, Bruyette & Woods, Inc. Regional Banking Index ("KRX"). 25% vesting will be based on the Company's average ROAA percentile performance as compared to KRX companies over the performance period. 25% vesting will be based on the Company's average ROATCE percentile performance as compared to the KRX companies over the performance period.
F8 Not applicable.